Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 28

    1.

    Impaired fasting glucose vs. glucose intolerance in pre-menopausal women: distinct metabolic entities and cardiovascular disease risk?

    Piché ME, Després JP, Pascot A, Nadeau A, Tremblay A, Weisnagel SJ, Bergeron J, Lemieux S.

    Diabet Med. 2004 Jul;21(7):730-7.PMID: 15209766 [PubMed - indexed for MEDLINE]Related articles

    2.

    Predictors of the development of impaired fasting glucose versus impaired glucose tolerance are partly different in men: a 6-year follow-up study.

    Piché ME, Després JP, Pascot A, Nadeau A, Tremblay A, Weisnagel SJ, Bergeron J, Lemieux S.

    Diabetologia. 2004 Mar;47(3):590-2. Epub 2004 Jan 29. No abstract available. PMID: 14749845 [PubMed - indexed for MEDLINE]Related articles

    3.

    Postprandial hyperlipidemia: another correlate of the "hypertriglyceridemic waist" phenotype in men.

    Blackburn P, Lamarche B, Couillard C, Pascot A, Bergeron N, Prud'homme D, Tremblay A, Bergeron J, Lemieux I, Després JP.

    Atherosclerosis. 2003 Dec;171(2):327-36.PMID: 14644404 [PubMed - indexed for MEDLINE]Related articles

    4.

    Contribution of visceral adiposity to the exaggerated postprandial lipemia of men with impaired glucose tolerance.

    Blackburn P, Lamarche B, Couillard C, Pascot A, Tremblay A, Bergeron J, Lemieux I, Després JP.

    Diabetes Care. 2003 Dec;26(12):3303-9.PMID: 14633818 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Impact of postprandial variation in triglyceridemia on low-density lipoprotein particle size.

    Blackburn P, Côté M, Lamarche B, Couillard C, Pascot A, Tremblay A, Bergeron J, Lemieux I, Després JP.

    Metabolism. 2003 Nov;52(11):1379-86.PMID: 14624394 [PubMed - indexed for MEDLINE]Related articles

    6.

    Gemfibrozil reduces plasma C-reactive protein levels in abdominally obese men with the atherogenic dyslipidemia of the metabolic syndrome.

    Després JP, Lemieux I, Pascot A, Alméras N, Dumont M, Nadeau A, Bergeron J, Prud'homme D.

    Arterioscler Thromb Vasc Biol. 2003 Apr 1;23(4):702-3. No abstract available. PMID: 12692010 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Is the gender difference in LDL size explained by the metabolic complications of visceral obesity?

    Lemieux I, Pascot A, Lamarche B, Prud'homme D, Nadeau A, Bergeron J, Després JP.

    Eur J Clin Invest. 2002 Dec;32(12):909-17.PMID: 12534450 [PubMed - indexed for MEDLINE]Related articles

    8.

    Effects of prednisone withdrawal on the new metabolic triad in cyclosporine-treated kidney transplant patients.

    Lemieux I, Houde I, Pascot A, Lachance JG, Noël R, Radeau T, Després JP, Bergeron J.

    Kidney Int. 2002 Nov;62(5):1839-47.PMID: 12371987 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Influences of the PPAR alpha-L162V polymorphism on plasma HDL(2)-cholesterol response of abdominally obese men treated with gemfibrozil.

    Bossé Y, Pascot A, Dumont M, Brochu M, Prud'homme D, Bergeron J, Després JP, Vohl MC.

    Genet Med. 2002 Jul-Aug;4(4):311-5.PMID: 12172398 [PubMed - indexed for MEDLINE]Related articles

    10.

    Evidence for impaired lipolysis in abdominally obese men: postprandial study of apolipoprotein B-48- and B-100-containing lipoproteins.

    Couillard C, Bergeron N, Pascot A, Alméras N, Bergeron J, Tremblay A, Prud'homme D, Després JP.

    Am J Clin Nutr. 2002 Aug;76(2):311-8.PMID: 12145000 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Determinants of HDL particle size in patients with the null (P207L) or defective (D9N) mutation in the lipoprotein lipase gene: the Québec LipD Study.

    Ruel IL, Gaudet D, Perron P, Pascot A, Després JP, Bergeron J, Julien P, Lamarche B.

    Atherosclerosis. 2002 Jun;162(2):269-76.PMID: 11996946 [PubMed - indexed for MEDLINE]Related articles

    12.

    Reduction of visceral adipose tissue during weight loss.

    Doucet E, St-Pierre S, Alméras N, Imbeault P, Mauriège P, Pascot A, Després JP, Tremblay A.

    Eur J Clin Nutr. 2002 Apr;56(4):297-304.PMID: 11965505 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    HDL particle size: a marker of the gender difference in the metabolic risk profile.

    Pascot A, Lemieux I, Bergeron J, Tremblay A, Nadeau A, Prud'homme D, Couillard C, Lamarche B, Després JP.

    Atherosclerosis. 2002 Feb;160(2):399-406.PMID: 11849664 [PubMed - indexed for MEDLINE]Related articles

    14.

    Total cholesterol/HDL cholesterol ratio vs LDL cholesterol/HDL cholesterol ratio as indices of ischemic heart disease risk in men: the Quebec Cardiovascular Study.

    Lemieux I, Lamarche B, Couillard C, Pascot A, Cantin B, Bergeron J, Dagenais GR, Després JP.

    Arch Intern Med. 2001 Dec 10-24;161(22):2685-92.PMID: 11732933 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Effect of a low-glycaemic index--low-fat--high protein diet on the atherogenic metabolic risk profile of abdominally obese men.

    Dumesnil JG, Turgeon J, Tremblay A, Poirier P, Gilbert M, Gagnon L, St-Pierre S, Garneau C, Lemieux I, Pascot A, Bergeron J, Després JP.

    Br J Nutr. 2001 Nov;86(5):557-68.PMID: 11737954 [PubMed - indexed for MEDLINE]Related articles

    16.

    Reduced HDL particle size as an additional feature of the atherogenic dyslipidemia of abdominal obesity.

    Pascot A, Lemieux I, Prud'homme D, Tremblay A, Nadeau A, Couillard C, Bergeron J, Lamarche B, Després JP.

    J Lipid Res. 2001 Dec;42(12):2007-14.PMID: 11734573 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    A new method for HDL particle sizing by polyacrylamide gradient gel electrophoresis using whole plasma.

    Pérusse M, Pascot A, Després JP, Couillard C, Lamarche B.

    J Lipid Res. 2001 Aug;42(8):1331-4.PMID: 11483636 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    [Fat distribution and metabolism]

    Després JP, Lemieux I, Tchernof A, Couillard C, Pascot A, Lemieux S.

    Diabetes Metab. 2001 Apr;27(2 Pt 2):209-14. Review. French. PMID: 11452212 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Elevated C-reactive protein: another component of the atherothrombotic profile of abdominal obesity.

    Lemieux I, Pascot A, Prud'homme D, Alméras N, Bogaty P, Nadeau A, Bergeron J, Després JP.

    Arterioscler Thromb Vasc Biol. 2001 Jun;21(6):961-7.PMID: 11397704 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Deterioration of the metabolic risk profile in women. Respective contributions of impaired glucose tolerance and visceral fat accumulation.

    Pascot A, Després JP, Lemieux I, Alméras N, Bergeron J, Nadeau A, Prud'homme D, Tremblay A, Lemieux S.

    Diabetes Care. 2001 May;24(5):902-8.PMID: 11347752 [PubMed - indexed for MEDLINE]Related articlesFree article

    21.

    The small, dense LDL phenotype as a correlate of postprandial lipemia in men.

    Lemieux I, Couillard C, Pascot A, Bergeron N, Prud'homme D, Bergeron J, Tremblay A, Bouchard C, Mauriège P, Després JP.

    Atherosclerosis. 2000 Dec;153(2):423-32.PMID: 11164432 [PubMed - indexed for MEDLINE]Related articles

    22.

    [Risk factors associated with obesity: a metabolic perspective]

    Després JP, Pascot A, Lemieux I.

    Ann Endocrinol (Paris). 2000 Dec;61 Suppl 6:31-38. Review. French. PMID: 11148334 [PubMed - indexed for MEDLINE]Related articles

    23.

    Metabolic heterogeneity underlying postprandial lipemia among men with low fasting high density lipoprotein cholesterol concentrations.

    Couillard C, Bergeron N, Bergeron J, Pascot A, Mauriège P, Tremblay A, Prud'homme D, Bouchard C, Després JP.

    J Clin Endocrinol Metab. 2000 Dec;85(12):4575-82.PMID: 11134111 [PubMed - indexed for MEDLINE]Related articlesFree article

    24.

    Contribution of visceral obesity to the deterioration of the metabolic risk profile in men with impaired glucose tolerance.

    Pascot A, Després JP, Lemieux I, Bergeron J, Nadeau A, Prud'homme D, Tremblay A, Lemieux S.

    Diabetologia. 2000 Sep;43(9):1126-35.PMID: 11043858 [PubMed - indexed for MEDLINE]Related articles

    25.

    Hypertriglyceridemic waist: A marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men?

    Lemieux I, Pascot A, Couillard C, Lamarche B, Tchernof A, Alméras N, Bergeron J, Gaudet D, Tremblay G, Prud'homme D, Nadeau A, Després JP.

    Circulation. 2000 Jul 11;102(2):179-84.PMID: 10889128 [PubMed - indexed for MEDLINE]Related articlesFree article

    26.

    Visceral adipose tissue and low-density lipoprotein particle size in middle-aged versus young men.

    Lemieux I, Pascot A, Tchernof A, Bergeron J, Prud'homme D, Bouchard C, Després JP.

    Metabolism. 1999 Oct;48(10):1322-7.PMID: 10535398 [PubMed - indexed for MEDLINE]Related articles

    27.

    Contribution of the cholesteryl ester transfer protein gene TaqIB polymorphism to the reduced plasma HDL-cholesterol levels found in abdominal obese men with the features of the insulin resistance syndrome.

    Vohl MC, Lamarche B, Pascot A, Leroux G, Prud'homme D, Bouchard C, Nadeau A, Després JP.

    Int J Obes Relat Metab Disord. 1999 Sep;23(9):918-25.PMID: 10490796 [PubMed - indexed for MEDLINE]Related articles

    28.

    Age-related increase in visceral adipose tissue and body fat and the metabolic risk profile of premenopausal women.

    Pascot A, Lemieux S, Lemieux I, Prud'homme D, Tremblay A, Bouchard C, Nadeau A, Couillard C, Tchernof A, Bergeron J, Després JP.

    Diabetes Care. 1999 Sep;22(9):1471-8.PMID: 10480511 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data

    Search details

    » See more...